Skip to Content
Merck
CN
  • Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung.

Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung.

Cell reports (2015-01-06)
Henry Danahay, Angelica D Pessotti, Julie Coote, Brooke E Montgomery, Donghui Xia, Aaron Wilson, Haidi Yang, Zhao Wang, Luke Bevan, Chris Thomas, Stephanie Petit, Anne London, Peter LeMotte, Arno Doelemeyer, Germán L Vélez-Reyes, Paula Bernasconi, Christy J Fryer, Matt Edwards, Paola Capodieci, Amy Chen, Marc Hild, Aron B Jaffe
ABSTRACT

The balance and distribution of epithelial cell types is required to maintain tissue homeostasis. A hallmark of airway diseases is epithelial remodeling, leading to increased goblet cell numbers and an overproduction of mucus. In the conducting airway, basal cells act as progenitors for both secretory and ciliated cells. To identify mechanisms regulating basal cell fate, we developed a screenable 3D culture system of airway epithelial morphogenesis. We performed a high-throughput screen using a collection of secreted proteins and identified inflammatory cytokines that specifically biased basal cell differentiation toward a goblet cell fate, culminating in enhanced mucus production. We also demonstrate a specific requirement for Notch2 in cytokine-induced goblet cell metaplasia in vitro and in vivo. We conclude that inhibition of Notch2 prevents goblet cell metaplasia induced by a broad range of stimuli and propose Notch2 neutralization as a therapeutic strategy for preventing goblet cell metaplasia in airway diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-FOXJ1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution